Wanbury Limited (WANBURY) - Total Liabilities
Based on the latest financial reports, Wanbury Limited (WANBURY) has total liabilities worth Rs3.49 Billion INR (≈ $37.78 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Wanbury Limited - Total Liabilities Trend (2006–2025)
This chart illustrates how Wanbury Limited's total liabilities have evolved over time, based on quarterly financial data. See WANBURY net working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Wanbury Limited Competitors by Total Liabilities
The table below lists competitors of Wanbury Limited ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
CO2 Energy Transition Corp. Common Stock
NASDAQ:NOEM
|
USA | $2.69 Million |
|
Bulten AB
ST:BULTEN
|
Sweden | Skr2.68 Billion |
|
Eastland Equity Bhd
KLSE:2097
|
Malaysia | RM254.27 Million |
|
Seoul Electronics & Telecom Co. Ltd
KQ:027040
|
Korea | ₩42.33 Billion |
|
Patriot One Technologies Inc
F:0PL
|
Germany | €10.94 Million |
|
Zevia Pbc
NYSE:ZVIA
|
USA | $24.21 Million |
|
Galleon Gold Corp
V:GGO
|
Canada | CA$36.83 Million |
|
Amogreentech Co.Ltd
KQ:125210
|
Korea | ₩108.59 Billion |
Liability Composition Analysis (2006–2025)
This chart breaks down Wanbury Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see WANBURY market cap overview.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.21 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | 0.03 | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 3.26 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.77 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Wanbury Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Wanbury Limited (2006–2025)
The table below shows the annual total liabilities of Wanbury Limited from 2006 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-03-31 | Rs3.55 Billion ≈ $38.35 Million |
+12.39% |
| 2024-03-31 | Rs3.16 Billion ≈ $34.13 Million |
-6.18% |
| 2023-03-31 | Rs3.36 Billion ≈ $36.37 Million |
-10.54% |
| 2022-03-31 | Rs3.76 Billion ≈ $40.66 Million |
-15.59% |
| 2021-03-31 | Rs4.45 Billion ≈ $48.17 Million |
+5.51% |
| 2020-03-31 | Rs4.22 Billion ≈ $45.65 Million |
-14.77% |
| 2019-03-31 | Rs4.95 Billion ≈ $53.57 Million |
+8.29% |
| 2018-03-31 | Rs4.57 Billion ≈ $49.47 Million |
-19.07% |
| 2017-03-31 | Rs5.65 Billion ≈ $61.12 Million |
+3.59% |
| 2016-03-31 | Rs5.46 Billion ≈ $59.00 Million |
-4.77% |
| 2015-03-31 | Rs5.73 Billion ≈ $61.96 Million |
+0.32% |
| 2014-03-31 | Rs5.71 Billion ≈ $61.76 Million |
-28.09% |
| 2013-03-31 | Rs7.94 Billion ≈ $85.89 Million |
+7.34% |
| 2012-03-31 | Rs7.40 Billion ≈ $80.01 Million |
+12.72% |
| 2011-03-31 | Rs6.56 Billion ≈ $70.99 Million |
+6.91% |
| 2010-03-31 | Rs6.14 Billion ≈ $66.40 Million |
-9.07% |
| 2009-03-31 | Rs6.75 Billion ≈ $73.02 Million |
+252.95% |
| 2007-03-31 | Rs1.91 Billion ≈ $20.69 Million |
+104.02% |
| 2006-03-31 | Rs937.71 Million ≈ $10.14 Million |
-- |
About Wanbury Limited
Wanbury Limited manufactures and sells formulations and active pharmaceutical ingredients (API) in India and internationally. The company offers formulations for anti-infectives, pain and analgesics, respiratory, gastroenterology, gynecology, rheumatology, and central nervous system, as well as for vitamins, minerals, and nutrition. It also provides API products for antidiabetics, antihistamines,… Read more